ArticleBreast cancer research : BCR2013

Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.

Sahra Borges et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.